Updated on 24 August 2026
Focusing on microRNA drug development and PDEV delivery system
Director at Golden Biotech Limited
China (Hong Kong)
About
Golden Biotech, founded by Professor Yangchao Chen's team from the Faculty of Medicine at CUHK, is a company based at Hong Kong Science Park and dedicated to the R&D of innovative RNA‑based drugs, utilizing extracellular vesicles as a delivery system. The company’s proprietary PDEV platform is a natural, biocompatible nanocarrier enabling targeted and sustained delivery. Its therapeutic pipeline covers lung cancer, COPD, rhinitis, eye diseases, and hair loss. In parallel, the same PDEV technology is applied to skincare products and intimate care gels.
Project Location
- China (Hong Kong)
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Operations
Main Project Sector
- Technology
Type(s) of Last Financing Round of the project (if Applicable)
- Equity (private)
Main Service(s) Required
- Information Technology Services
- Transportation Services
Attached files
Similar opportunities
Investment Target
- Requisition of Service
- Public–private partnership / Concession
Daniel Poon
CEO Office Director at CF PharmTech, Inc. 长风药业股份有限公司
China (Hong Kong)
Project
Integrated platform-based innovative biopharma for inhalation formulations
- Yes
- Yes
- Bio-Tech
- Manufacturing
- Private Project
- Health Technology
- Medical Technology
- Financial Services
- Institutional Investment
- Secondary Market Financing
- Investment / Financing Discussion
Ting Su
IR at CF PharmTech, Inc. 长风药业股份有限公司
China
Project
Integrated platform-based innovative biopharma for inhalation formulations
- Yes
- Yes
- Bio-Tech
- Manufacturing
- Private Project
- Health Technology
- Medical Technology
- Financial Services
- Institutional Investment
- Secondary Market Financing
- Investment / Financing Discussion
Bill Liang
Chairperson & CEO at CF PharmTech, Inc. 长风药业股份有限公司
China